Statins After Bypass Lower Stroke Risk ( The cholesterol-busting drugs could b...)

Statins After Bypass Lower Stroke Risk

Date:11/6/2007

The cholesterol-busting drugs could be lifesavers, study suggsts

TUESDAY, Nov. 6 (HealthDay News) -- Treatment with cholesterol-lowering statin drugs after coronary artery bypass graft (CABG) surgery reduces a patient's risk of stroke, U.S. researchers report.

The study, from the Cleveland Clinic, included more than 5,200 patients who underwent bypass between early 1993 and late 2005. The overall incidence of post-operative stroke one year after surgery was 3.3 percent (181 strokes).

"Patients discharged on statin therapy were more likely to have a lower low-density cholesterol (LDL or "bad" cholesterol) and were significantly less likely to suffer a post-operative stroke at one year," the researchers wrote.

They also said that age, peripheral vascular disease and kidney disease were independent predictors of stroke, heart attack or death. The use of both statin and ACE inhibitors significantly reduced risk, they found.

"These data suggest that a discharge regimen including statin therapy may reduce post-operative morbidity and warrants prospective validation," the researchers concluded.

The study was to be presented Tuesday at the American Heart Association annual meeting, in Orlando, Fla.

More information

The Society of Thoracic Surgeons has more about CABG.

-- Robert Preidt

SOURCE: Nov. 6, 2007, presentation, American Heart Association annual meeting, Orlando, Fla.

0

GOOD

Post Your Comments:

(Date:3/22/2010)... Oklahoma-based health management company partners with nationally-recognized orthopedic hospital. , ... ... Cornerstone Healthcare Partners has entered into an agreement with ... the Tower Day Surgery Center and the Orthopedic Hospital, ... is now responsible for the day to day operation of the ...

(Date:3/21/2010)... ... , , ... ... ... Today the House of Representatives passed the Senate health care bill with a multitude of abortion funding provisions and passed the reconciliation bill to increase ...

(Date:3/21/2010)... on the House floor tonight in support of historic health insurance reform legislation. The House ... 212. That bill now goes to the President for his signature into law. A second ... goes to the Senate. Below are the Speaker,s remarks. , ... ... , ...

(Date:3/21/2010)... Online dealer for used stair lifts, 4 Stair Lifts, will now buy ... working order, and sell them at discounted prices. , ... (Vocus) March ... it will now buy back used stair lifts from AmeriGlide ... longer need them, and then make sure they are working correctly before ...

(Date:3/21/2010)... ROCHESTER, Minn. -- A five-center collaborative study that scanned the ... as well as healthy never smokers has found a gene ... those cancers. , In the March 22 on line issue ... that about 30 percent of patients who never smoked and ... allele, residing in a gene known as GPC5. The research ...

[0] Cornerstone Health Corporation Named Manager of Orthopedic Institute's Hospital and Tower Day Surgery Center [0] Pro-Life Movement Vows to Replace Members From Pro-life Districts Who Voted for the Most Pro-Abortion Bill Ever Passed by Congress [0] Pelosi: 'Today, We Have the Opportunity to Complete the Great Unfinished Business of Our Society and Pass Health Insurance Reform for All Americans'[0] 4 Stair Lifts Announces Used Stair Lift Buy Back Program [0] Gene is linked to lung cancer development in never-smokers

... appear to curb compulsive acting out, study says , , ... Parkinson,s disease drugs called dopamine agonists can cause patients ... hypersexuality, says a new study. , Mayo Clinic ... doses of dopamine agonists, such as pramipexole and ropinirole, ...

... to allow citizens to use their own words, not government ... will is a national resource for advance care planning - ... Aging with Dignity, a national non-profit organization that ... joins with thousands of other organizations nationwide on April 16th ...

... study by Mount Sinai faculty suggests that a gene ... Alzheimer,s disease dementia cases. The research, led by Dr. ... in Neurology, and Professor of Psychiatry and Geriatrics and ... published this week in the scientific journal, Archives ...

... Trinity College Dublin published in this month,s Annals ... in the treatment of patients undergoing major cancer surgery. ... group at Trinity College Dublin and St James,s Hospital. ... as part of an oral nutritional supplement resulted in ...

... times a scientific article is cited by other articles is ... offers another measure: the number of unique downloads. , ... finds that downloads are a good predictor of citations ... was published in an editorial by Journal of Vision ...

... FRIDAY, April 10 (HealthDay News) -- Debate about the ideal age ... U.S. economy in a dramatic slump, the flip side of that ... become uppermost in many people,s minds. , As workers young and ... mortgage crisis and stock market tumbles, they joke that they,ll have ...

Other Medicine News:Health News:Parkinson's Drugs Can Trigger Unhealthy Behaviors 2 Health News:Aging with Dignity Celebrates National Healthcare Decisions Day 2 Health News:Mount Sinai researchers discover novel mechanisms that might causally link type-2 diabetes to Alzheimer's disease 2 Health News:Omega-3 fatty acids may benefit cancer patients undergoing major operations 2 Health News:Omega-3 fatty acids may benefit cancer patients undergoing major operations 3 Health News:Omega-3 fatty acids may benefit cancer patients undergoing major operations 4 Health News:How Old Is Too Old to Work? 2 Health News:How Old Is Too Old to Work? 3

Parkinson's Drugs Can Trigger Unhealthy Behaviors Aging with Dignity Celebrates National Healthcare Decisions Day Mount Sinai researchers discover novel mechanisms that might causally link type-2 diabetes to Alzheimer's disease Omega-3 fatty acids may benefit cancer patients undergoing major operations Can downloads predict impact for scientific articles?How Old Is Too Old to Work?

(Date:3/18/2010)... PITTSBURGH , March 18 ChemImage, a ... present the results of an ingredient-specific particle sizing (ISPST) ... Respiratory Drug Delivery (RDD) 2010 ( www.rddonline.com ). This ... 29th in Orlando, Florida and will ...

(Date:3/18/2010)... the "Company"), an international biopharmaceutical company with,operations in the U.S. and China , is pleased to announce the exercise of a,warrant by a principal shareholder, RimAsia Capital ... ... ... ...

(Date:3/18/2010)... HARBIN, China , March 18 ... One Medical" or "the Company") (Nasdaq: CSKI ... in the People,s Republic of China ... anti-cancer drug co-developed by Taiwan,Golden Biotechnology Corporation ("Golden ...

Breaking Medicine Technology:ChemImage's Raman Chemical Imaging Used for Ingredient-Specific Particle Sizing for Inhalation Product Development 2 ChemImage's Raman Chemical Imaging Used for Ingredient-Specific Particle Sizing for Inhalation Product Development 3 NeoStem Announces Warrant Exercise by Principal Shareholder 2 NeoStem Announces Warrant Exercise by Principal Shareholder 3 NeoStem Announces Warrant Exercise by Principal Shareholder 4 NeoStem Announces Warrant Exercise by Principal Shareholder 5 China Sky One Medical Announces Antroquinonol Capsule Recognized as Breakthrough Drug by Chinese Ministry of Science and Technology 2 China Sky One Medical Announces Antroquinonol Capsule Recognized as Breakthrough Drug by Chinese Ministry of Science and Technology 3 China Sky One Medical Announces Antroquinonol Capsule Recognized as Breakthrough Drug by Chinese Ministry of Science and Technology 4 China Sky One Medical Announces Antroquinonol Capsule Recognized as Breakthrough Drug by Chinese Ministry of Science and Technology 5 Brain Imaging Study Sheds Light on Fibromyalgia 49502 1 Pages to Doctors Dont Always Hit the Mark 49499 1 Pages to Doctors Dont Always Hit the Mark 49499 2 Pages to Doctors Dont Always Hit the Mark 49499 3 Brio Active Brings Whole Body Vibration Fitness to Cherry Hills Village 49496 1 Brio Active Brings Whole Body Vibration Fitness to Cherry Hills Village 49496 2

[0] ChemImage's Raman Chemical Imaging Used for Ingredient-Specific Particle Sizing for Inhalation Product Development [0] NeoStem Announces Warrant Exercise by Principal Shareholder [0] China Sky One Medical Announces Antroquinonol Capsule Recognized as Breakthrough Drug by Chinese Ministry of Science and Technology

... Data from Open-Label Study Presented at Federation ... CARLSBAD, Calif., June 11, 2007 /PRNewswire-FirstCall/ --,Orchestra ... new data from its completed Phase II ... Receptor (TCR) peptide,vaccine for the treatment of ...

... /PRNewswire-FirstCall/ -- Vion,Pharmaceuticals, Inc. announced that it ... the 12th Congress of the European Hematology,Association ... lead anticancer,agent Cloretazine(R) (VNP40101M) as a single ... trial in a subset of,elderly patients with ...

Other Medicine Technology:Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 2 Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 3 Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 4 Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 5 Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial,of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable,Cytogenetics at EHA Meeting 2 Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial,of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable,Cytogenetics at EHA Meeting 3 Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial,of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable,Cytogenetics at EHA Meeting 4

Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial,of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable,Cytogenetics at EHA Meeting

Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 8.0 mm and length 10 mm....

Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 7.0 mm and length 10 mm....

Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm....

Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 6 mm....

Medicine Products:

Sugita Aneurysm Clip L-Shaped Cvd. To L(L)Sugita Aneurysm Clip L-Shaped (L)Sugita Aneurysm Clip Bent (S)Sugita Aneurysm Clip J-Shaped (S)

Statins After Bypass Lower Stroke Risk( The cholesterol-busting drugs could b...),Health